- /
- Supported exchanges
- / US
- / AARD.NASDAQ
Aardvark Therapeutics, Inc. Common Stock (AARD NASDAQ) stock market data APIs
Aardvark Therapeutics, Inc. Common Stock Financial Data Overview
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Aardvark Therapeutics, Inc. Common Stock (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Aardvark Therapeutics, Inc. Common Stock data using free add-ons & libraries
Get Aardvark Therapeutics, Inc. Common Stock Fundamental Data
Aardvark Therapeutics, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA: -73 913 000
- Earnings Per Share: -3
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Aardvark Therapeutics, Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-11-12
- EPS/Forecast: -0.69
Get Aardvark Therapeutics, Inc. Common Stock End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Aardvark Therapeutics, Inc. Common Stock News
New
Agilent Technologies' Q4 Earnings on Deck: What's in Store for the Stock?
Agilent Technologies, Inc. A is slated to release fourth-quarter fiscal 2026 results on Nov. 23, after market close. The original equipment manufacturer posted adjusted earnings per share (EPS) of $1...
Sector Update: Healthcare Stocks Fall Late Afternoon
Healthcare stocks were lower late Friday afternoon, with the NYSE Healthcare Index dropping 1.3% and PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Aardvark Therapeutics stock surges as FDA lifts clinical hold
Investing.com -- Aardvark Therapeutics Inc (NASDAQ:AARD) shares jumped 21% in after-hours trading Thursday after the FDA lifted the clinical hold on the company's ARD-101 drug candidate for the treatm...
Prader-Willi Syndrome Market to Expand by 2036 as New Therapeutic Opportunities Address Unmet Clinical Needs | DelveInsight
The Prader-Willi syndrome market is expected to grow steadily, driven by increasing disease awareness, improved diagnosis, and the development of novel targeted therapies such as WAKIX (Harmony Biosci...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.